دورية أكاديمية

1093TiP An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE]

التفاصيل البيبلوغرافية
العنوان: 1093TiP An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE]
المؤلفون: Aroldi, F., Middleton, M.R., Sacco, J.J., Milhem, M.M., Curti, B.D., VanderWalde, A.M., Baum, S.L., Samson, A., Chesney, J., Niu, J., Rhodes, T.D., Bowles, T.L., Olsson-Brown, A., Laux, D.E., Bommareddy, P.K., Menezes, L., Samakoglu, S., Pirzkall, A., Coffin, R.S., Harrington, K.J.
المصدر: In Annals of Oncology September 2021 32 Supplement 5:S903-S904
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2021.08.1478